Product mentioned on podcasts
Libtayo
by Regeneron
Mentioned on 1 episode by 1 guest across our covered podcasts.
SignalCast may earn commission on purchases via these links.
Who mentioned it
“Planned anti-PD-1 study with Regeneron's Libtayo in non-small cell lung cancer, with first patient dosing targeted for second-half 2025”
Mentioned on: The Bio Report